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Characterization of RNA Aptamer Binding to Rift Valley Fever Virus Nucleocapsid Protein
Ilona Csik and Katherine Hornak
Division of Biological Sciences, The University of Montana, Missoula, Montana 59812
Background
Rift Valley fever virus (RVFV) is a mosquito-borne virus that can cause hemorrhagic fever in humans and 
miscarriage in livestock. Originally endemic to sub-Saharan Africa, RVFV has now spread to the Arabian 
Peninsula as well.1 There is currently no cure for RVFV. Viral nucleocapsid protein (N) binds to viral RNA 
during RVFV replication and transcription, and it coats the viral genome to protect the viral genetic material.
2, 3 Thus, disruption of N-RNA interaction is a good potential therapeutic target for a new class of antiviral 
drugs. To exploit this target, it is essential to understand how N recognizes viral RNA sequences specifically. 
The Lodmell laboratory previously discovered a small RNA shown to bind N with high affinity called MBE87.4 
MBE87 contains two GAUU nucleotide motifs that we hypothesize to be important for N binding. To test this 
hypothesis we designed and constructed RNAs with the same predicted secondary structure as MBE87 but 
with GAUU motifs at different positions in the structure, and assessed the binding affinity of N to the 
different RNA constructs by electrophoretic mobility shift assays.
Methods and Materials
In-silico designed aptamer sequences with identical predicted secondary structures but different primary 
sequences were cloned into expression plasmids and amplified in E. coli cells. Large-scale DNA 
preparations of these plasmids were preformed and used as templates for in vitro RNA transcriptions to 
make the novel RNA aptamers with strategically placed GAUU motifs. α-32P UTP was used in the 
transcription reaction to produce internally (32P) labeled RNA. Using the MBE87 aptamer and an aptamer 
devoid of GAUU motifs as controls, electrophoretic mobility shift assays were performed to qualitatively 
compare the extent of RNA-N binding between constructs. N protein concentration started at 10 μM and 
was diluted 1.5-fold over 13 reactions. 100 μM suramin (in DMSO) was present in reactions. Controls – RNA 
alone and N-RNA without suramin – were each prepared with 1 µL of DMSO present to control for the 
suramin stock solvent. 11 800 counts of labeled RNA (2 µL) were then added to reactions. Reactions were 
incubated at room temperature for 30 minutes. Reactions and controls were run on 6% PA-1x TB gels.  
Percent of RNA bound to N was quantified using ImageGauge software (Fuji Medical Systems).   
Figures 1-3. From left to right: Figure 1 shows the aptamer MBE87_17. Figure 2 shows the aptamer MBE87_21. 
17 and 21 signify GAUU placement in the aptamers. Figure 3 shows the aptamer MBE87, the high affinity binder 
from which the other constructs were derived using a genetic algorithm created by Dr. Douglas Raiford (UM). 
The algorithm allows for relocation of the GAUU motif while retaining the secondary structure of MBE87. 
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Figure 5. EMSA band 
intensity data from 
Figure 4 for all four 
constructs was 
quantified using 
ImageGauge software 
(Fuji). These binding data 
indicate higher binding 
affinity of the MBE87 and 
MBE87_17 constructs.
Figure 4A. MBE87.  Figure 4B. No GAUU. 
Figure 4C. MBE87_17.  Figure 4D. MBE87_21.  
Conclusions
We determined that MBE87 binds to N with the highest affinity. MBE87_17 also binds to N with 
high affinity. MBE87_21 binds to N with less affinity than MBE87_17. The construct without the 
GAUU motif binds to N with lower affinity as well, indicating that the presence of the GAUU 
motif may be important for RNA recognition by N. However, these results suggest that the 
positioning of the GAUU in relation to secondary structural elements may be important for 
recognition and binding by N, too. MBE87 and MBE87_17, with GAUU positioned partially in a 
double-stranded region, bound to N with higher affinity than MBE87_21, with GAUU positioned 
only in a largely single-stranded region. It is possible that both GAUUs situated in each of these 
2° elements are needed for optimal binding, as MBE87 still binds with slightly higher affinity than 
MBE87_17. It is also possible that N recognizes a sequence motif other than GAUU entirely, or 
that N simply requires a recognizable general 2° structure to bind aptamers. Studies to 
investigate further possibilities are underway. 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Figure 4. Electrophoretic mobility shift results for constructs. N protein concentration starts at 
10 μM in the left-most lane and is diluted 1.5-fold (6.7 μM, 4.4 μM, 2.96 μM, 1.98 μM, 1.32 μM, 
0.88 μM, 0.59 μM, 0.39 μM, 0.26 μM, 0.17 μM, 0.12 μM, 0.077 μM from left to right – lanes 2-13). 
The N-RNA control is in lane 14; the RNA control is in lane 15 (right-most lane) for all constructs. 
At higher N concentration, more RNA is expected to be bound and thus present in the top band.
ßFree RNA
ßN-RNA complex
ßFree RNA
ßN-RNA complex
ßFree RNA
ßN-RNA complex
ßFree RNA
ßN-RNA complex
Research Question
Does Rift Valley fever virus nucleocapsid protein recognize a  primary nucleotide sequence, a specific 
secondary structure, or both when binding RNA?
